Starting dose | Maximum dose limit | Dosage adjustment | |
---|---|---|---|
Nondialysis | 100 mg orally thrice in a week [Dosing 2 days apart but not 4 days apart] | 150 mg | According to the patient’s haemoglobin (Hb) level every 4 weeks (Table 1) |
Dialysis | Erythropoiesis-stimulating Agent (ESA)-naïve patients: 100 mg orally thrice in a week [Dosing 2 days apart but not 4 days apart] ESA-experienced patients: 100 mg or 125 mg or 150 mg thrice in a week [Dosing 2 days apart but not 4 days apart] |
150 mg | ESA-experienced patients based on previous Epoetin/ Darbepoetin/Methoxy polyethylene glycol-epoetin beta dose (Table 2) |
|
Change in Hb g% level every 4 weeks | Hb <10 g% | Hb 10 to <11 g% | Hb 11 to <12 g% | Hb ≥12 g% |
---|---|---|---|---|
<1.0 increase | Increase the dose | Increase the dose | Maintain the dose | Stop the treatment for 14 days, initiate one lower dose if Hb <11.5 g% |
≥1.0 increase to ≤2.0 increase |
Maintain the dose | Maintain the dose | Decrease the dose | |
>2.0 increase | Maintain the dose | Decrease the dose | Decrease the dose | |
|
Epoetin (IU/week) | Darbepoetin (µg/week) | Methoxy polyethylene glycol-epoetin beta (µg/month) | Desidustat (mg, three times in a week) |
---|---|---|---|
<8000 | <40 | <120 | <100 |
8000 to 16000 | 40-80 | 120-200 | 125 |
>16000 | >80 | >200 | >150 |
No incidence of overdose with Desidustat has been reported. In case of overdose with Desidustat, healthcare professional (HCP) to be consulted if symptoms deteriorate. General supportive care of the patient is indicated, including monitoring of vital signs and observation of clinical status.
When a patient misses a dose of Desidustat, next scheduled dose will be administered to the subjects. However, missed dose will not be administered to the subject.
REFERENCES:
#Desidustat package insert dated 21st Feb 2022.